Skip to content

Effective Interventions to Overcome Severe Gag Reflex

Effective Interventions to Overcome Severe Gag Reflex

Status
Not yet recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07099131
Enrollment
45
Registered
2025-08-01
Start date
2025-12-07
Completion date
2028-12-07
Last updated
2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gagging

Brief summary

The purpose of this study is to evaluate the use of various techniques in alleviating gag reflex following gag reflex stimulation. Primary aim: To compare if there is any reduction in gag reflex from each of the following interventions * Acupuncture (CV-24) * Tape * Anesthetic spray Secondary aim: to compare the degree of gag reduction

Detailed description

The purpose of this study is to evaluate the use of various techniques in alleviating gag reflex following gag reflex stimulation. Primary aim: To compare if there is any reduction in gag reflex from each of the following interventions * Acupuncture (CV-24) * Tape * Anesthetic spray Secondary aim: to compare the degree of gag reduction

Interventions

DRUGAnesthetic spray

will be applied to back of the throat for 10 seconds; their chin will also be concealed from the GSI examiner using a small cup and masking tape.

DEVICEAcupuncture

A 6C file (endodontic instrumentation file) will be placed on the patient's mentolabial fold (CV24). This file will be concealed by a small paper cup; A clean alcohol wipe will be used to clean the mentolabial area prior to placing the acupuncture needle (6 C-File).

A piece of commercially available masking tape will be adhered to the patient's mentolabial fold and concealed by the small paper cup

Sponsors

Tufts University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Unblinded. Subjects will be randomized. The three intervention groups are : Acupuncture (CV-24), Tape and Anesthetic Spray.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older (individuals below 18 years will be excluded from the study as the study procedures might not be well tolerated by them, and they are not the primary population on which these procedures are used). * Students, faculty, or staff of Tufts SDM * Subjects who score a 2 or higher on the Gagging Severity Index (GSI)7 and have a positive gag reflex response when stimulated with a cotton swab at the base of the tongue/uvula/tonsil region.

Exclusion criteria

* Adults unable to consent (cognitively impaired adults) * Wards of the state * Pregnant women (those that are self-reported) * Current use of anticoagulants * Allergy to xylocaine * Those with bleeding disorders * Those who participated in the Calibration phase of this study

Design outcomes

Primary

MeasureTime frameDescription
Change in Gag Reflex Severity Index (GSI) Score From Pre- to Post-Intervention90 minutes per subjectChange in Gag Reflex Severity Index (GSI) Score From Baseline to Post-Intervention * Acupuncture (CV-24) * Tape * Anesthetic spray Gag reflex severity will be assessed by clinicians using the Gagging Severity Index (GSI), based on definitions set by Dickinson and Fiske. GSI will first be recorded after initial gag stimulation with a cotton swab. Following randomization to one of three interventions (acupuncture, anesthetic spray, or masking tape), GSI will be recorded again. The change in GSI score will be used to measure change in gag response.

Secondary

MeasureTime frameDescription
Self-Reported Degree of Gag Reflex Reduction Using Visual Analog Scale (VAS)Immediately post-intervention during single study visitParticipants will complete an in-session survey to rate their gag reflex severity after the assigned intervention using a Visual Analog Scale (VAS). The VAS rating reflects the participant's perception of gag reduction following either acupuncture at CV24, anesthetic spray, or masking tape application.

Countries

United States

Contacts

Primary ContactDevon Ptak
devon.ptak@tufts.edu6176366889

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026